CENTRAL NERVOUS SYSTEM (CNS) LESIONS

Clinical trials for CENTRAL NERVOUS SYSTEM (CNS) LESIONS explained in plain language.

Never miss a new study

Get alerted when new CENTRAL NERVOUS SYSTEM (CNS) LESIONS trials appear

Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM (CNS) LESIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New brain scan dye tested as safer alternative

Diagnosis Completed

This study tested a new MRI contrast agent called RVP-001, which uses manganese instead of gadolinium, to see if it could safely and effectively detect lesions in the brain and central nervous system. It involved 18 adults with known conditions like brain tumors or multiple scler…

Matched conditions: CENTRAL NERVOUS SYSTEM (CNS) LESIONS

Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis

Last updated Mar 30, 2026 14:30 UTC

CENTRAL NERVOUS SYSTEM (CNS) LESIONS

Get alerted when new CENTRAL NERVOUS SYSTEM (CNS) LESIONS trials appear

New brain scan dye tested as safer alternative